In over three decades, Joe Kiani led Masimo from a California startup into a global leader in patient monitoring. Since his resignation in late 2024, Kiani has not slowed down but rather redirected his energy into a series of ventures that combine health, technology, and human connection.
Continuing a Legacy of Health Innovation
Soon after his departure, Kiani deepened his focus on Willow Laboratories, a company he founded in 1998 to advance human health through data and behavioral insights. Willow’s mission centers on empowering people to manage their health proactively rather than reactively.
A key part of that mission is Nutu, a digital platform designed to help individuals improve their well-being through small, measurable changes in diet, activity, and sleep. The app uses wearable data and user inputs to generate a “Nutu Score,” a personalized indicator of progress. The system emphasizes gradual lifestyle improvements and sustained engagement, rather than one-size-fits-all recommendations.
The company’s approach reflects Kiani’s longstanding belief that technology should simplify health decisions and help people live longer, healthier lives.
Entering Media Technology with Like Minded Labs
In July 2025, Kiani became CEO of Like Minded Labs, a Santa Monica–based media technology company focused on transforming digital communication and creative collaboration.
Former Disney CEO Bob Chapek also joined the company’s board around the same time, highlighting its focus on scalable, content-driven innovation.
Kiani’s leadership at Like Minded Labs appears to be grounded in the same principles that guided his previous ventures: technical rigor, long-term thinking, and a commitment to products that improve the way people connect.
A Consistent Commitment to Safety and Purpose
Kiani continues to chair the Patient Safety Movement Foundation, which he established in 2012 to reduce preventable deaths in hospitals worldwide. The foundation works with healthcare providers, policymakers, and technology companies to share best practices and advance transparency in patient outcomes.
This ongoing advocacy reinforces a throughline across all of Kiani’s work: a dedication to applying technology ethically and effectively to improve human wellbeing. Whether in hospital systems, personal health apps, or media platforms, his focus remains on how innovation can serve people more directly.
Strategic Investments in Healthcare Innovation
Kiani has also recently put capital, board roles, and domain expertise into emerging and established health-tech ventures, including MY01, SMS Biotech, IRIDAMED, and CDX Medical Technologies, all of which reinforce a commitment to transforming the frontiers of medical care.
Building on a Proven Foundation
Joe Kiani’s professional trajectory shows a consistent pattern: identify a problem, build the technology to address it, and scale that solution until it changes an industry.
While the industries and companies have evolved, the core mission remains clear: leveraging engineering and creativity to make technology serve humanity more effectively.
